Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.

Pantziarka P, Bouche G.

Cancer J. 2019 Mar/Apr;25(2):100-105. doi: 10.1097/PPO.0000000000000361.

PMID:
30896531
2.

ReDO_DB: the repurposing drugs in oncology database.

Pantziarka P, Verbaanderd C, Sukhatme V, Rica Capistrano I, Crispino S, Gyawali B, Rooman I, Van Nuffel AM, Meheus L, Sukhatme VP, Bouche G.

Ecancermedicalscience. 2018 Dec 6;12:886. doi: 10.3332/ecancer.2018.886. eCollection 2018.

3.

[Hypofractionated radiotherapy in rectal cancer for elderly patients].

Servagi Vernat S, Guilbert P, Bouché G, Ramiandrisoa F, Bellefqih S.

Cancer Radiother. 2018 Oct;22(6-7):644-646. doi: 10.1016/j.canrad.2018.07.130. Epub 2018 Aug 27. Review. French.

PMID:
30166091
4.

"Hard" Drug Repurposing for Precision Oncology: The Missing Link?

Pantziarka P, Bouche G, André N.

Front Pharmacol. 2018 Jun 14;9:637. doi: 10.3389/fphar.2018.00637. eCollection 2018. No abstract available.

5.

Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.

Pantziarka P, Sukhatme V, Crispino S, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2018 Apr 11;12:824. doi: 10.3332/ecancer.2018.824. eCollection 2018.

6.

Does the oncology community have a rejection bias when it comes to repurposed drugs?

Gyawali B, Pantziarka P, Crispino S, Bouche G.

Ecancermedicalscience. 2018 Jan 16;12:ed76. doi: 10.3332/ecancer.2018.ed76. eCollection 2018.

7.

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.

Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, Agostinis P, Bouche G.

Ecancermedicalscience. 2017 Nov 23;11:781. doi: 10.3332/ecancer.2017.781. eCollection 2017.

8.

Cancer care: Tap latent source of frugal cancer ideas.

Bouche G.

Nature. 2017 Oct 11;550(7675):188. doi: 10.1038/550188a. No abstract available.

PMID:
29022585
9.

Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugs.

Pantziarka P, Bouche G, Sullivan R, Ilbawi AM, Dare AJ, Meheus L.

Eur J Surg Oncol. 2017 Nov;43(11):1985-1988. doi: 10.1016/j.ejso.2017.08.010. Epub 2017 Sep 7.

PMID:
28928011
10.

Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Pantziarka P, Bouche G, Sukhatme V, Meheus L, Rooman I, Sukhatme VP.

Ecancermedicalscience. 2016 Oct 12;10:680. eCollection 2016.

11.

Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.

Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2016 Jan 11;10:610. doi: 10.3332/ecancer.2016.610. eCollection 2016.

12.

Drug repurposing in oncology--patient and health systems opportunities.

Bertolini F, Sukhatme VP, Bouche G.

Nat Rev Clin Oncol. 2015 Dec;12(12):732-42. doi: 10.1038/nrclinonc.2015.169. Epub 2015 Oct 20. Review.

PMID:
26483297
13.

Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.

Sukhatme V, Bouche G, Meheus L, Sukhatme VP, Pantziarka P.

Ecancermedicalscience. 2015 Aug 27;9:568. doi: 10.3332/ecancer.2015.568. eCollection 2015.

14.

Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.

Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2015 Apr 15;9:521. doi: 10.3332/ecancer.2015.521. eCollection 2015.

15.

Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G.

Ecancermedicalscience. 2015 Feb 24;9:513. doi: 10.3332/ecancer.2015.513. eCollection 2015.

16.

Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Future Oncol. 2015;11(2):181-4. doi: 10.2217/fon.14.244. No abstract available.

17.

Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Ecancermedicalscience. 2014 Nov 26;8:485. doi: 10.3332/ecancer.2014.485. eCollection 2014.

18.

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.

Bouche G, André N, Banavali S, Berthold F, Berruti A, Bocci G, Brandi G, Cavallaro U, Cinieri S, Colleoni M, Curigliano G, Di Desidero T, Eniu A, Fazio N, Kerbel R, Hutchinson L, Ledzewicz U, Munzone E, Pasquier E, Graciela Scharovsky O, Shaked Y, Stěrba J, Villalba M, Bertolini F.

Ecancermedicalscience. 2014 Sep 9;8:463. doi: 10.3332/ecancer.2014.463. eCollection 2014.

19.

Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Ecancermedicalscience. 2014 Jul 10;8:443. doi: 10.3332/ecancer.2014.443. eCollection 2014.

20.

The Repurposing Drugs in Oncology (ReDO) Project.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP, Vikas P.

Ecancermedicalscience. 2014 Jul 10;8:442. doi: 10.3332/ecancer.2014.442. eCollection 2014.

21.

Inconsistencies and questionable reliability of the publication "immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF" by Yamamoto et al.

Ugarte A, Bouche G, Meheus L.

Cancer Immunol Immunother. 2014 Dec;63(12):1347-8. doi: 10.1007/s00262-014-1587-y. Epub 2014 Jul 24. No abstract available.

22.

Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in Belgium.

Werbrouck J, Bouche G, de Jonge E, Jacomen G, D'Hondt V, Denys H, Van Limbergen E, Vandermeersch B, De Schutter H, Van Eycken E, Goffin F, Amant F.

Gynecol Oncol. 2013 Dec;131(3):512-9. doi: 10.1016/j.ygyno.2013.10.001. Epub 2013 Oct 6.

PMID:
24103471
23.

Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial.

Forget P, Berlière M, van Maanen A, Duhoux FP, Machiels JP, Coulie PG, Bouche G, De Kock M; Ketorolac in Breast Cancer trial (KBCtrial) group.

Med Hypotheses. 2013 Oct;81(4):707-12. doi: 10.1016/j.mehy.2013.07.033. Epub 2013 Aug 9.

PMID:
23937996
24.

Sleep disorders and multiple sclerosis: a clinical and polysomnography study.

Neau JP, Paquereau J, Auche V, Mathis S, Godeneche G, Ciron J, Moinot N, Bouche G.

Eur Neurol. 2012;68(1):8-15. doi: 10.1159/000335076. Epub 2012 May 23.

PMID:
22627080
25.

Microbiology of facial cellulitis related to dental infection.

Kouassi YM, Janvier B, Dufour X, Bouche G, Klossek JM.

Med Mal Infect. 2011 Oct;41(10):540-5. doi: 10.1016/j.medmal.2011.01.014. Epub 2011 Sep 9.

PMID:
21907512
26.

Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid.

Dominguez C, Karayan-Tapon L, Desurmont T, Gibelin H, Crespin S, Fromont G, Levillain P, Bouche G, Cantereau A, Mesnil M, Kraimps JL.

Thyroid. 2011 Oct;21(10):1057-66. doi: 10.1089/thy.2011.0041. Epub 2011 Aug 29.

PMID:
21875346
27.

[Tests and scales: restrains to use them by general practitioners. Descriptive transversal study].

Cario C, Levesque JL, Bouche G.

Rev Prat. 2010 Dec 20;60(10 Suppl):24-8. French.

PMID:
22530272
28.

Restless legs syndrome and pregnancy: a questionnaire study in the Poitiers District, France.

Neau JP, Porcheron A, Mathis S, Julian A, Meurice JC, Paquereau J, Godeneche G, Ciron J, Bouche G.

Eur Neurol. 2010;64(5):268-74. doi: 10.1159/000321413. Epub 2010 Oct 27.

PMID:
20980760
29.

Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer.

Bouche G, Ingrand I, Mathoulin-Pelissier S, Ingrand P, Breton-Callu C, Migeot V.

Radiother Oncol. 2010 Dec;97(3):541-7. doi: 10.1016/j.radonc.2010.09.011. Epub 2010 Oct 13.

PMID:
20950880
30.

[High resolution sonography of the dorsal radiocarpal and intercarpal ligaments: findings in healthy subjects with anatomic correlation to cadaveric wrists].

Bihan M, Pesquer L, Meyer P, Paris G, Rousvoal A, Bouche G, Tasu JP.

J Radiol. 2009 Jul-Aug;90(7-8 Pt 1):813-7. French.

PMID:
19752786
31.

Usefulness of pulse oximetry using the SET technology in critically ill adult patients.

Levrat Q, Petitpas F, Bouche G, Debaene B, Mimoz O.

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):640-4. doi: 10.1016/j.annfar.2009.05.017.

PMID:
19595560
32.

[Application of detecting and taking overdispersion into account in Poisson regression model].

Bouche G, Lepage B, Migeot V, Ingrand P.

Rev Epidemiol Sante Publique. 2009 Aug;57(4):285-96. doi: 10.1016/j.respe.2009.02.209. Epub 2009 Jun 21. French.

PMID:
19540683
33.
34.
35.

Does the risk of compressive hematoma after thyroidectomy authorize 1-day surgery?

Leyre P, Desurmont T, Lacoste L, Odasso C, Bouche G, Beaulieu A, Valagier A, Charalambous C, Gibelin H, Debaene B, Kraimps JL.

Langenbecks Arch Surg. 2008 Sep;393(5):733-7. doi: 10.1007/s00423-008-0362-y. Epub 2008 Jul 3.

PMID:
18597109
36.

Breast cancer surgery: do all patients want to go to high-volume hospitals?

Bouche G, Migeot V, Mathoulin-Pélissier S, Salamon R, Ingrand P.

Surgery. 2008 Jun;143(6):699-705. doi: 10.1016/j.surg.2008.03.013. Epub 2008 May 9.

PMID:
18549885
37.

Usefulness of the short IQCODE for predicting postoperative delirium in elderly patients undergoing hip and knee replacement surgery.

Priner M, Jourdain M, Bouche G, Merlet-Chicoine I, Chaumier JA, Paccalin M.

Gerontology. 2008;54(2):116-9. doi: 10.1159/000117574. Epub 2008 Feb 18.

PMID:
18285677
38.

[Imogam rage prescription assessment in the rabies prophylaxis center of Poitiers].

Albouy-Llaty M, Le Moal G, Bouche G, Dupuis A, Becq-Giraudon B, Migeot V.

Med Mal Infect. 2007 Feb;37(2):108-11. Epub 2007 Jan 23. French.

PMID:
17254729
39.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.

Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):282-7. Epub 2006 Dec 21.

40.

Lack of correlation between nutritional status and seroprotection against influenza in a long term care facility.

Paccalin M, Plouzeau C, Bouche G, Guillard O, Beby-Defaux A, Mauco G, Agius G.

Scand J Infect Dis. 2006;38(10):894-7.

PMID:
17008234
41.

[Automatic recall of didactic knowledge in semantic memory during normal aging and in Alzheimer's disease].

Pluchon C, Simonnet E, Bouche G, Hugon J, Gil R.

Rev Neurol (Paris). 2006 Jun;162(6-7):713-20. French.

PMID:
16840979
42.

[Identification errors and delusions of false identification in Alzheimer's disease: a regional survey].

Nedelec-Ciceri C, Chaumier JA, Lussier MD, Merlet-Chicoine I, Bouche G, Paccalin M, Gil R.

Rev Neurol (Paris). 2006 May;162(5):628-36. French.

PMID:
16710129
43.

Antiphospholipid syndrome in patients with retinal venous occlusion.

Paccalin M, Manic H, Bouche G, Landron C, Mercié M, Boinot C, Gombert JM, Roblot P, Dighiero P.

Thromb Res. 2006;117(4):365-9.

PMID:
16461072
44.

Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.

Carrière V, Colisson R, Jiguet-Jiglaire C, Bellard E, Bouche G, Al Saati T, Amalric F, Girard JP, M'Rini C.

Cancer Res. 2005 Dec 15;65(24):11639-48.

45.

[Automobile driving among patients with dementia. Survey in the Poitou-Charentes region].

Paccalin M, Bouche G, Barc-Pain S, Merlet-Chicoine I, Nedelec C, Gil R.

Presse Med. 2005 Jul 23;34(13):919-22. French.

PMID:
16142148
46.

[Scarf osteotomy for the treatment of hallux valgus: a review of 123 cases with 4.8 years follow-up].

Freslon M, Gayet LE, Bouche G, Hamcha H, Nebout J, Pries P.

Rev Chir Orthop Reparatrice Appar Mot. 2005 May;91(3):257-66. French.

PMID:
15976670
47.

Exogenously added fibroblast growth factor 2 (FGF-2) to NIH3T3 cells interacts with nuclear ribosomal S6 kinase 2 (RSK2) in a cell cycle-dependent manner.

Soulet F, Bailly K, Roga S, Lavigne AC, Amalric F, Bouche G.

J Biol Chem. 2005 Jul 8;280(27):25604-10. Epub 2005 May 6.

48.
49.

Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion.

Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E.

Cardiovasc Res. 2004 Apr 1;62(1):154-66.

PMID:
15023562
50.

Fibroblast growth factor-2 interacts with free ribosomal protein S19.

Soulet F, Al Saati T, Roga S, Amalric F, Bouche G.

Biochem Biophys Res Commun. 2001 Nov 30;289(2):591-6.

PMID:
11716516

Supplemental Content

Loading ...
Support Center